About Reprise Biomedical
Reprise Biomedical is a private company based in Plymouth, Minnesota. It has reported $56,377,862 raised in six offerings on Form D since July 2019. Its chief executive is Carrie Powers.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| May 14, 2026 | May 21, 2026amended Jul 1, 2026 | $9,246,100of $10.0M target | 43 | $215K | EquityRule 506(b) | Form D/A ↗1 earlier filing |
| Jun 26, 2025 | Jul 11, 2025 | $6,356,956of $7.0M target | 14 | $454K | EquityRule 506(b) | Form D ↗ |
| Oct 19, 2023 | Nov 2, 2023amended Dec 13, 2023 | $7,982,500of $12.5M target | 77 | $103K | EquityRule 506(b) | Form D/A ↗1 earlier filing |
| Dec 20, 2022 | Jan 3, 2023amended Jan 25, 2023 | $15,297,306fully sold | 64 | $239K | EquityRule 506(b) | Form D/A ↗1 earlier filing |
| Nov 13, 2020 | Nov 25, 2020amended Mar 31, 2021 | $4,995,000of $5.0M target | 39 | $128K | EquityRule 506(b) | Form D/A ↗1 earlier filing |
| Jun 28, 2019 | Jul 12, 2019 | $12,500,000fully sold | 51 | $245K | Equity, OptionsRule 506(b) | Form D ↗ |
| Total, six offerings | $56,377,862 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Reprise Biomedical's Form D filed Jul 1, 2026.
PN
HR
Howard Root
Director
SJ
Steve Jagodzinski
Controller and Treasurer
AW
Alan Woldt
Director
RE
Ronald Eibensteiner
Director
EK
Erwin Kelen
Director
Earlier filings also listed Tina Walters (executive officer, last listed Dec 2023), Phillip Nalbone (director, last listed Jan 2023) and Jeff Ross (director, last listed Mar 2021).